ACIP Poliomyelitis Prevention Recommendations: U.S. Vaccination Policy Update (1999)

The Advisory Committee on Immunization Practices (ACIP) issued updated recommendations in 1999 to replace the 1997 guidelines. These recommendations detail the exclusive use of inactivated poliovirus vaccine (IPV) for routine childhood vaccination in the United States, outlining a four-dose schedule. Authored by D. Rebecca Prevots, the text discusses the rationale for the policy shift away from oral poliovirus vaccine (OPV) to eliminate the risk of vaccine-associated paralytic poliomyelitis.

Use Cases

• Analyzing the evolution of polio vaccination policy based on the detailed historical recommendations.
• Studying the rationale for vaccine schedule changes based on the discussion of VAPP risk and global eradication progress.
• Modeling the impact of policy shifts on public health outcomes based on the described historical context and coverage data.

Strengths

• Provides a specific historical policy change date (June 17, 1999) and the effective date (January 1, 2000).
• Cites concrete historical data, such as the risk of VAPP being one case among 2.4 million OPV doses distributed.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Advisory Committee on Immunization Practices (ACIP), authored by D. Rebecca Prevots.

Collection Method

Policy recommendations and guidelines.

Time Range

Primary focus on 1999 update, referencing data from 1979 and 1997.

Geography

United States.